Cardlytics, Inc. (CDLX): Nasdaq/NYSE listing notice — Cardlytics receives Nasdaq deficiency notice; implements 1-for-10 reverse stock split

Cardlytics, Inc.

Nasdaq notified CDLX that bid price closed below $1 for 30 consecutive days; 180-day cure period ends Nov 30, 2026.
Company filed Charter Amendment for 1-for-10 reverse stock split effective June 5, 2026; trading on split-adjusted basis June 8.
Authorized shares reduced from 100M to 10M; outstanding shares to drop from ~58M to ~5.8M, subject to fractional cash-out.
Proportionate adjustments made to 4.25% Convertible Notes due 2029, stock options, and RSUs.
If compliance not met by Nov 30, CDLX may seek second 180-day period or face delisting; reverse split aims to cure deficiency.

item 3.01 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cardlytics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

June 3, 2026, Cardlytics, Inc., a Delaware corporation (the “ Company ”), received a letter from the Listing Qualifications Staff (the “ Nasdaq Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Market. In accordance with

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cardlytics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5810(c)(3)(A)

Exact text from the filing

June 3, 2026, Cardlytics, Inc., a Delaware corporation (the “ Company ”), received a letter from the Listing Qualifications Staff (the “ Nasdaq Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Market. In accordance with

View on SEC.gov

Browse all listing & compliance notices →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-040351

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.